VYNE Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
5.17
|
|
Average Rating
|
4.25
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.17
|
-0.16
|
0.01
|
5.88%
|
|
2022-06-30
|
-0.17
|
-0.15
|
0.02
|
11.76%
|
|
2022-03-31
|
-0.16
|
0.08
|
0.24
|
150.00%
|
|
2021-12-31
|
-0.24
|
-0.20
|
0.04
|
16.67%
|
|
2021-09-30
|
-0.32
|
-0.36
|
-0.04
|
-12.50%
|
|
2021-06-30
|
-0.35
|
-0.35
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.41
|
-0.37
|
0.04
|
9.76%
|
|
2020-12-31
|
-0.53
|
-0.55
|
-0.02
|
-3.77%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.23
|
|
2021-12-31
|
-1.28
|
|
2020-12-31
|
-9.79
|
|
2019-12-31
|
-12.36
|
|
2018-12-31
|
-4.68
|
|
2017-12-31
|
-3.41
|